SOLV Solventum Corporation
HealthcareAs of 2026-05-26
Valuation
View DetailsP/E (TTM)
6.97
PEG
0.03
P/B
2.69
P/S
1.61
EV/EBITDA
6.46
DCF Value
$153.32
FCF Yield
-1.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
53.7%
Operating Margin
25.5%
Net Margin
17.3%
ROE
30.7%
ROA
10.2%
ROIC
15.9%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $2.01B | $13.0M | $— |
| Q4 null | $2.00B | $63.0M | $— |
| FY null | $8.32B | $1.56B | $— |
| Q3 null | $2.10B | $1.27B | $— |
Analyst Ratings
View AllConsensus
Hold
Target (Consensus)
$92.43
Target (Median)
$93.00
Target Range
$78.00 - $100.00
Trading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
Medical - Care Facilities
Country
US
Exchange
—
Beta
0.66
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.